148 related articles for article (PubMed ID: 38795681)
21. Evaluation of the Completeness of Interventions Reported in Published Randomized Controlled Trials in Plastic Surgery: A Systematic Review.
Evans S; Rauh S; Jellison S; Diener B; Agha R; Vassar M
Aesthet Surg J; 2021 May; 41(6):707-719. PubMed ID: 32530461
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of intervention reporting in published emergency medicine clinical trials.
Fladie IA; Rorah D; Pollard J; Jellison S; Thabane L; Murray K; Gardner G; Vassar M
Am J Emerg Med; 2020 Jun; 38(6):1171-1177. PubMed ID: 32340822
[TBL] [Abstract][Full Text] [Related]
23. Completeness of intervention reporting in neurology randomized controlled trials: a retrospective, cross-sectional study.
Roberts W; Beavers C; Jellison S; Vassar M
Int J Evid Based Healthc; 2020 Jun; 18(2):212-221. PubMed ID: 32487965
[TBL] [Abstract][Full Text] [Related]
24. Adherence to the PRISMA statement and its association with risk of bias in systematic reviews published in rehabilitation journals: A meta-research study.
Innocenti T; Feller D; Giagio S; Salvioli S; Minnucci S; Brindisino F; Cosentino C; Piano L; Chiarotto A; Ostelo R
Braz J Phys Ther; 2022; 26(5):100450. PubMed ID: 36270163
[TBL] [Abstract][Full Text] [Related]
25. Guidelines for Reporting Outcomes in Trial Protocols: The SPIRIT-Outcomes 2022 Extension.
Butcher NJ; Monsour A; Mew EJ; Chan AW; Moher D; Mayo-Wilson E; Terwee CB; Chee-A-Tow A; Baba A; Gavin F; Grimshaw JM; Kelly LE; Saeed L; Thabane L; Askie L; Smith M; Farid-Kapadia M; Williamson PR; Szatmari P; Tugwell P; Golub RM; Monga S; Vohra S; Marlin S; Ungar WJ; Offringa M
JAMA; 2022 Dec; 328(23):2345-2356. PubMed ID: 36512367
[TBL] [Abstract][Full Text] [Related]
26. Guidelines for reporting pediatric and child health clinical trial protocols and reports: study protocol for SPIRIT-Children and CONSORT-Children.
Baba A; Smith M; Potter BK; Chan AW; Moher D; Offringa M
Trials; 2024 Jan; 25(1):96. PubMed ID: 38287439
[TBL] [Abstract][Full Text] [Related]
27. Do pharmacy intervention reports adequately describe their interventions? A template for intervention description and replication analysis of reports included in a systematic review.
de Barra M; Scott C; Johnston M; De Bruin M; Scott N; Matheson C; Bond C; Watson M
BMJ Open; 2019 Dec; 9(12):e025511. PubMed ID: 31862736
[TBL] [Abstract][Full Text] [Related]
28. Reporting quality of randomised controlled trial abstracts on age-related macular degeneration health care: a cross-sectional quantification of the adherence to CONSORT abstract reporting recommendations.
Baulig C; Krummenauer F; Geis B; Tulka S; Knippschild S
BMJ Open; 2018 May; 8(5):e021912. PubMed ID: 29789352
[TBL] [Abstract][Full Text] [Related]
29. Enhancing reporting through structure: a before and after study on the effectiveness of SPIRIT-based templates to improve the completeness of reporting of randomized controlled trial protocols.
Blanco D; Donadio MVF; Cadellans-Arróniz A
Res Integr Peer Rev; 2024 May; 9(1):6. PubMed ID: 38816752
[TBL] [Abstract][Full Text] [Related]
30. Intervention Reporting of Published Trials Is Insufficient in Orthopaedic Surgery Journals: Application of the Template for Intervention Description and Replication Checklist.
Anderson JM; Stafford A; Jellison S; Vassar M
Arthrosc Sports Med Rehabil; 2021 Jun; 3(3):e619-e627. PubMed ID: 34195624
[TBL] [Abstract][Full Text] [Related]
31. Are CONSORT checklists submitted by authors adequately reflecting what information is actually reported in published papers?
Blanco D; Biggane AM; Cobo E;
Trials; 2018 Jan; 19(1):80. PubMed ID: 29378640
[TBL] [Abstract][Full Text] [Related]
32. Endorsement for improving the quality of reports on randomized controlled trials of traditional medicine journals in Korea: a systematic review.
Choi J; Jun JH; Kang BK; Kim KH; Lee MS
Trials; 2014 Nov; 15():429. PubMed ID: 25373427
[TBL] [Abstract][Full Text] [Related]
33. Nonregistration, discontinuation, and nonpublication of randomized trials: A repeated metaresearch analysis.
Speich B; Gryaznov D; Busse JW; Gloy VL; Lohner S; Klatte K; Taji Heravi A; Ghosh N; Lee H; Mansouri A; Marian IR; Saccilotto R; Nury E; Kasenda B; Ojeda-Ruiz E; Schandelmaier S; Tomonaga Y; Amstutz A; Pauli-Magnus C; Bischoff K; Wollmann K; Rehner L; Meerpohl JJ; Nordmann A; Wong J; Chow N; Hong PJ; Mc Cord-De Iaco K; Sricharoenchai S; Agarwal A; Schwenkglenks M; Hemkens LG; von Elm E; Copsey B; Griessbach AN; Schönenberger C; Mertz D; Blümle A; von Niederhäusern B; Hopewell S; Odutayo A; Briel M
PLoS Med; 2022 Apr; 19(4):e1003980. PubMed ID: 35476675
[TBL] [Abstract][Full Text] [Related]
34. How completely are randomized controlled trials of non-pharmacological interventions following concussion reported? A systematic review.
van Ierssel JJ; Galea O; Holte K; Luszawski C; Jenkins E; O'Neil J; Emery CA; Mannix R; Schneider K; Yeates KO; Zemek R
J Sport Health Sci; 2024 Jul; 13(4):537-547. PubMed ID: 37619783
[TBL] [Abstract][Full Text] [Related]
35. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
36. Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension.
Calvert M; Kyte D; Mercieca-Bebber R; Slade A; Chan AW; King MT; ; Hunn A; Bottomley A; Regnault A; Chan AW; Ells C; O'Connor D; Revicki D; Patrick D; Altman D; Basch E; Velikova G; Price G; Draper H; Blazeby J; Scott J; Coast J; Norquist J; Brown J; Haywood K; Johnson LL; Campbell L; Frank L; von Hildebrand M; Brundage M; Palmer M; Kluetz P; Stephens R; Golub RM; Mitchell S; Groves T
JAMA; 2018 Feb; 319(5):483-494. PubMed ID: 29411037
[TBL] [Abstract][Full Text] [Related]
37. Systematic evaluation of the patient-reported outcome (PRO) content of clinical trial protocols.
Kyte D; Duffy H; Fletcher B; Gheorghe A; Mercieca-Bebber R; King M; Draper H; Ives J; Brundage M; Blazeby J; Calvert M
PLoS One; 2014; 9(10):e110229. PubMed ID: 25333349
[TBL] [Abstract][Full Text] [Related]
38. Reporting of interventions in randomised trials: an audit of journal instructions to authors.
Hoffmann T; English T; Glasziou P
Trials; 2014 Jan; 15():20. PubMed ID: 24422788
[TBL] [Abstract][Full Text] [Related]
39. Strategies to improve the implementation of workplace-based policies or practices targeting tobacco, alcohol, diet, physical activity and obesity.
Wolfenden L; Goldman S; Stacey FG; Grady A; Kingsland M; Williams CM; Wiggers J; Milat A; Rissel C; Bauman A; Farrell MM; Légaré F; Ben Charif A; Zomahoun HTV; Hodder RK; Jones J; Booth D; Parmenter B; Regan T; Yoong SL
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012439. PubMed ID: 30480770
[TBL] [Abstract][Full Text] [Related]
40. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
